text
"['\n1. 요약재무정보\n1) 요약 연결재무제표\n주식회사 에이프로젠메디신과 그 종속기업\n(단위 : 원)\n구 \xa0 \xa0 \xa0분\n제 52(당) 분기\n제 51(전)기\n제 50(전전)기\n1. 요약 재무상태표\n(2022년 03월 31일 현재)\n(2021년 12월 31일 현재)\n(2020년 12월 31일 현재)\n[유동자산]\n511,632,417,954\n484,328,008,669\n434,503,626,705\n\xa0 현금및현금성자산(\n45,353,529,287\n62,377,862,586\n96,615,613,661\n\xa0 매출채권및기타유동채권\n342,593,567,841\n295,911,773,785\n176,692,946,588\n\xa0 기타유동금융자산\n77,470,198,908\n97,430,749,491\n140,847,031,595\n\xa0 재고자산\n23,694,708,537\n20,899,396,536\n17,301,767,529\n\xa0 기타유동자산\n1,933,142,975\n4,205,943,153\n1,546,373,388\n\xa0 당기법인세자산\n3,840,609,020\n3,502,283,118\n1,499,893,944\n\xa0 매각예정비유동자산\n16,746,661,386\n-\n-\n[비유동자산]\n311,409,887,939\n339,783,824,939\n399,804,808,843\n\xa0 기타비유동채권\n145,962,711,172\n146,257,943,156\n142,143,080,004\n\xa0 기타비유동금융자산\n67,633,232,693\n70,884,680,890\n105,289,769,913\n\xa0 관계기업 투자주식\n45,243,009,763\n53,107,501,253\n78,283,860,466\n\xa0 유형자산\n38,118,983,059\n39,251,835,256\n40,186,271,362\n\xa0 무형자산\n3,360,261,705\n3,067,190,944\n3,842,233,372\n\xa0 투자부동산\n8,807,948,485\n24,957,328,927\n27,217,446,260\n\xa0 기타비유동자산\n27,040,559\n49,021,129\n53,613,749\n\xa0 이연법인세자산\n2,256,700,503\n2,208,323,384\n2,788,533,717\n자 산 총 계\n823,042,305,893\n824,111,833,608\n834,308,435,548\n[유동부채]\n101,468,317,207\n110,758,603,253\n85,094,012,932\n[비유동부채]\n10,736,027,216\n8,990,787,852\n59,174,540,433\n부 채 총 계\n112,204,344,423\n119,749,391,105\n144,268,553,365\n[지배기업의 소유주지분]\n341,306,450,076\n335,950,869,202\n318,978,122,532\n\xa0 자본금\n102,555,635,000\n99,577,615,000\n91,473,126,500\n\xa0 자본잉여금\n374,520,733,866\n369,796,245,565\n339,378,917,903\n\xa0 기타자본구성요소\n9,128,934,693\n9,128,934,693\n9,128,934,693\n\xa0 기타포괄손익누계액\n(37,580,969,751)\n(37,299,658,860)\n(35,637,222,413)\n\xa0 이익잉여금(결손금)\n(107,317,883,732)\n(105,252,267,196)\n(85,365,634,151)\n[비지배지분]\n369,531,511,394\n368,411,573,301\n371,061,759,651\n자 본 총 계\n710,837,961,470\n704,362,442,503\n690,039,882,183\n2. 요약 포괄손익계산서\n(2022.1.1~2022.03.31)\n(2021.1.1~2021.12.31)\n(2020.1.1~2020.12.31)\n매출액\n41,931,747,143\n141,247,001,612\n127,142,624,221\n영업이익(손실)\n4,772,965\n(2,672,313,559)\n3,971,180,948\n당기순이익(손실)\n226,216,449\n(12,500,351,319)\n(32,668,134,383)\n- 지배기업소유주지분순이익(손실)\n(1,867,675,878)\n(18,002,111,538)\n(46,489,934,346)\n- 비지배지분순이익(손실)\n2,093,892,327\n5,501,760,219\n13,821,799,963\n기본주당순이익(손실)\n(9)\n(93)\n(274)\n희석주당순이익(손실)\n(9)\n(93)\n(274)\n연결에 포함된 회사 수\n8\n8\n7\n2) 요약 별도재무제표\n주식회사 에이프로젠메디신\n(단위 : 원)\n구 \xa0 \xa0 \xa0분\n제 52(당) 분기\n제 51(전)기\n제 50(전전)기\n1. 요약 재무상태표\n(2022년 03월 31일 현재)\n(2021년 12월 31일 현재)\n(2020년 12월 31일 현재)\n[유동자산]\n186,771,415,800\n163,683,628,832\n160,211,445,512\n\xa0 현금및현금성자산\n25,966,730,644\n24,266,596,895\n31,007,805,768\n\xa0 매출채권및기타유동채권\n129,322,299,084\n125,275,630,784\n120,685,619,879\n\xa0 기타유동금융자산\n-\n571,226,477\n569,957,755\n\xa0 재고자산\n12,350,963,031\n9,157,286,884\n6,837,643,551\n\xa0 기타유동자산\n1,124,826,386\n3,152,952,523\n1,110,418,559\n\xa0 당기법인세자산\n1,259,935,269\n1,259,935,269\n-\n\xa0 매각예정비유동자산\n16,746,661,386\n-\n-\n[비유동자산]\n391,767,344,295\n410,603,947,697\n423,872,435,990\n\xa0 기타비유동채권\n569,947,368\n441,904,223\n529,273,082\n\xa0 기타비유동금융자산\n59,528,806,022\n61,542,067,170\n74,451,680,828\n\xa0 종속기업 투자주식\n204,134,594,354\n204,134,594,354\n200,519,898,582\n\xa0 관계기업 투자주식\n106,572,500,000\n106,572,500,000\n106,572,500,000\n\xa0 유형자산\n19,017,109,664\n19,879,734,216\n21,193,324,758\n\xa0 무형자산\n242,676,590\n222,895,397\n162,849,891\n\xa0 투자부동산\n1,701,710,297\n17,810,252,337\n18,364,544,292\n\xa0 이연법인세자산\n-\n-\n2,078,364,557\n자산총계\n578,538,760,095\n574,287,576,529\n584,083,881,502\n[유동부채]\n213,936,570,666\n222,693,310,505\n208,066,883,654\n[비유동부채]\n3,537,478,423\n1,935,005,653\n51,898,140,868\n부채총계\n217,474,049,089\n224,628,316,158\n259,965,024,522\n\xa0 자본금\n102,555,635,000\n99,577,615,000\n91,473,126,500\n\xa0 자본잉여금\n375,212,537,444\n370,488,049,143\n340,070,291,662\n\xa0 기타자본구성요소\n8,222,142,729\n8,222,142,729\n8,222,142,729\n\xa0 기타포괄손익누계액\n(37,637,948,760)\n(37,674,849,907)\n(39,021,928,137)\n\xa0 이익잉여금(결손금)\n(87,287,655,407)\n(90,953,696,594)\n(76,624,775,774)\n자본총계\n361,064,711,006\n349,659,260,371\n324,118,856,980\n종속기업 투자주식 평가방법\n원가법\n원가법\n원가법\n관계기업 및 공동기업 투자주식 평가방법\n원가법\n원가법\n원가법\n2. 요약 포괄손익계산서\n(2022.1.1~2022.03.31)\n(2021.1.1~2021.12.31)\n(2020.1.1~2020.12.31)\n매출액\n23,116,379,687\n81,081,675,768\n72,536,685,082\n영업이익(손실)\n604,191,376\n295,275,849\n6,419,293,909\n당기순이익(손실)\n3,782,917,683\n(12,040,893,501)\n(46,864,368,222)\n기본주당순이익(손실)\n19\n(62)\n(276)\n희석주당순이익(손실)\n25\n(62)\n(276)\n']"
